DocMorris AG
DocMorris AG (ZRSEF) Stock Competitors & Peer Comparison
See (ZRSEF) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Pharmaceuticals Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| ZRSEF | $10.57 | +0.00% | 508.5M | -2.14 | -$4.93 | N/A |
| ALBHF | $0.62 | +0.00% | 10B | 62.00 | $0.01 | N/A |
| ALBBY | $12.15 | +0.00% | 9.8B | 48.60 | $0.25 | N/A |
| MSMKF | $21.20 | +0.00% | 8.4B | 23.56 | $0.90 | +1.42% |
| DCHPF | $46.90 | -0.21% | 5.3B | -151.29 | -$0.31 | N/A |
| CLCGY | $42.06 | -1.52% | 5B | 30.04 | $1.41 | +0.54% |
| RGEDF | $27.17 | +0.00% | 5B | 7.99 | $3.40 | +4.85% |
| GEDSF | $24.85 | +0.00% | 4.5B | 10.71 | $2.32 | +5.89% |
| RADLY | $2.79 | +15.86% | 4.3B | 19.38 | $0.13 | +2.30% |
| CSMYF | $46.06 | +0.00% | 3.7B | 19.77 | $2.33 | +1.03% |
Stock Comparison
ZRSEF vs ALBHF Comparison August 2025
ZRSEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZRSEF stands at 508.5M. In comparison, ALBHF has a market cap of 10B. Regarding current trading prices, ZRSEF is priced at $10.57, while ALBHF trades at $0.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZRSEF currently has a P/E ratio of -2.14, whereas ALBHF's P/E ratio is 62.00. In terms of profitability, ZRSEF's ROE is -0.26%, compared to ALBHF's ROE of +0.06%. Regarding short-term risk, ZRSEF is more volatile compared to ALBHF. This indicates potentially higher risk in terms of short-term price fluctuations for ZRSEF.Check ALBHF's competition here
ZRSEF vs ALBBY Comparison August 2025
ZRSEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZRSEF stands at 508.5M. In comparison, ALBBY has a market cap of 9.8B. Regarding current trading prices, ZRSEF is priced at $10.57, while ALBBY trades at $12.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZRSEF currently has a P/E ratio of -2.14, whereas ALBBY's P/E ratio is 48.60. In terms of profitability, ZRSEF's ROE is -0.26%, compared to ALBBY's ROE of +0.06%. Regarding short-term risk, ZRSEF is more volatile compared to ALBBY. This indicates potentially higher risk in terms of short-term price fluctuations for ZRSEF.Check ALBBY's competition here
ZRSEF vs MSMKF Comparison August 2025
ZRSEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZRSEF stands at 508.5M. In comparison, MSMKF has a market cap of 8.4B. Regarding current trading prices, ZRSEF is priced at $10.57, while MSMKF trades at $21.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZRSEF currently has a P/E ratio of -2.14, whereas MSMKF's P/E ratio is 23.56. In terms of profitability, ZRSEF's ROE is -0.26%, compared to MSMKF's ROE of +0.11%. Regarding short-term risk, ZRSEF is more volatile compared to MSMKF. This indicates potentially higher risk in terms of short-term price fluctuations for ZRSEF.Check MSMKF's competition here
ZRSEF vs DCHPF Comparison August 2025
ZRSEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZRSEF stands at 508.5M. In comparison, DCHPF has a market cap of 5.3B. Regarding current trading prices, ZRSEF is priced at $10.57, while DCHPF trades at $46.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZRSEF currently has a P/E ratio of -2.14, whereas DCHPF's P/E ratio is -151.29. In terms of profitability, ZRSEF's ROE is -0.26%, compared to DCHPF's ROE of N/A. Regarding short-term risk, ZRSEF is more volatile compared to DCHPF. This indicates potentially higher risk in terms of short-term price fluctuations for ZRSEF.Check DCHPF's competition here
ZRSEF vs CLCGY Comparison August 2025
ZRSEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZRSEF stands at 508.5M. In comparison, CLCGY has a market cap of 5B. Regarding current trading prices, ZRSEF is priced at $10.57, while CLCGY trades at $42.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZRSEF currently has a P/E ratio of -2.14, whereas CLCGY's P/E ratio is 30.04. In terms of profitability, ZRSEF's ROE is -0.26%, compared to CLCGY's ROE of +0.49%. Regarding short-term risk, ZRSEF is more volatile compared to CLCGY. This indicates potentially higher risk in terms of short-term price fluctuations for ZRSEF.Check CLCGY's competition here
ZRSEF vs RGEDF Comparison August 2025
ZRSEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZRSEF stands at 508.5M. In comparison, RGEDF has a market cap of 5B. Regarding current trading prices, ZRSEF is priced at $10.57, while RGEDF trades at $27.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZRSEF currently has a P/E ratio of -2.14, whereas RGEDF's P/E ratio is 7.99. In terms of profitability, ZRSEF's ROE is -0.26%, compared to RGEDF's ROE of +0.20%. Regarding short-term risk, ZRSEF is more volatile compared to RGEDF. This indicates potentially higher risk in terms of short-term price fluctuations for ZRSEF.Check RGEDF's competition here
ZRSEF vs GEDSF Comparison August 2025
ZRSEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZRSEF stands at 508.5M. In comparison, GEDSF has a market cap of 4.5B. Regarding current trading prices, ZRSEF is priced at $10.57, while GEDSF trades at $24.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZRSEF currently has a P/E ratio of -2.14, whereas GEDSF's P/E ratio is 10.71. In terms of profitability, ZRSEF's ROE is -0.26%, compared to GEDSF's ROE of +0.19%. Regarding short-term risk, ZRSEF is more volatile compared to GEDSF. This indicates potentially higher risk in terms of short-term price fluctuations for ZRSEF.Check GEDSF's competition here
ZRSEF vs RADLY Comparison August 2025
ZRSEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZRSEF stands at 508.5M. In comparison, RADLY has a market cap of 4.3B. Regarding current trading prices, ZRSEF is priced at $10.57, while RADLY trades at $2.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZRSEF currently has a P/E ratio of -2.14, whereas RADLY's P/E ratio is 19.38. In terms of profitability, ZRSEF's ROE is -0.26%, compared to RADLY's ROE of +0.18%. Regarding short-term risk, ZRSEF is more volatile compared to RADLY. This indicates potentially higher risk in terms of short-term price fluctuations for ZRSEF.Check RADLY's competition here
ZRSEF vs CSMYF Comparison August 2025
ZRSEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZRSEF stands at 508.5M. In comparison, CSMYF has a market cap of 3.7B. Regarding current trading prices, ZRSEF is priced at $10.57, while CSMYF trades at $46.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZRSEF currently has a P/E ratio of -2.14, whereas CSMYF's P/E ratio is 19.77. In terms of profitability, ZRSEF's ROE is -0.26%, compared to CSMYF's ROE of +0.08%. Regarding short-term risk, ZRSEF is more volatile compared to CSMYF. This indicates potentially higher risk in terms of short-term price fluctuations for ZRSEF.Check CSMYF's competition here
ZRSEF vs WLCGF Comparison August 2025
ZRSEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZRSEF stands at 508.5M. In comparison, WLCGF has a market cap of 3.4B. Regarding current trading prices, ZRSEF is priced at $10.57, while WLCGF trades at $16.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZRSEF currently has a P/E ratio of -2.14, whereas WLCGF's P/E ratio is 19.54. In terms of profitability, ZRSEF's ROE is -0.26%, compared to WLCGF's ROE of +0.06%. Regarding short-term risk, ZRSEF is more volatile compared to WLCGF. This indicates potentially higher risk in terms of short-term price fluctuations for ZRSEF.Check WLCGF's competition here
ZRSEF vs SDGCF Comparison August 2025
ZRSEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZRSEF stands at 508.5M. In comparison, SDGCF has a market cap of 3.3B. Regarding current trading prices, ZRSEF is priced at $10.57, while SDGCF trades at $28.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZRSEF currently has a P/E ratio of -2.14, whereas SDGCF's P/E ratio is 17.40. In terms of profitability, ZRSEF's ROE is -0.26%, compared to SDGCF's ROE of +0.12%. Regarding short-term risk, ZRSEF is more volatile compared to SDGCF. This indicates potentially higher risk in terms of short-term price fluctuations for ZRSEF.Check SDGCF's competition here
ZRSEF vs SHPPF Comparison August 2025
ZRSEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZRSEF stands at 508.5M. In comparison, SHPPF has a market cap of 3B. Regarding current trading prices, ZRSEF is priced at $10.57, while SHPPF trades at $148.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZRSEF currently has a P/E ratio of -2.14, whereas SHPPF's P/E ratio is -73.38. In terms of profitability, ZRSEF's ROE is -0.26%, compared to SHPPF's ROE of -0.10%. Regarding short-term risk, ZRSEF is more volatile compared to SHPPF. This indicates potentially higher risk in terms of short-term price fluctuations for ZRSEF.Check SHPPF's competition here
ZRSEF vs SGIPF Comparison August 2025
ZRSEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZRSEF stands at 508.5M. In comparison, SGIPF has a market cap of 2.9B. Regarding current trading prices, ZRSEF is priced at $10.57, while SGIPF trades at $16.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZRSEF currently has a P/E ratio of -2.14, whereas SGIPF's P/E ratio is 20.11. In terms of profitability, ZRSEF's ROE is -0.26%, compared to SGIPF's ROE of +0.11%. Regarding short-term risk, ZRSEF is more volatile compared to SGIPF. This indicates potentially higher risk in terms of short-term price fluctuations for ZRSEF.Check SGIPF's competition here
ZRSEF vs TSUSF Comparison August 2025
ZRSEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZRSEF stands at 508.5M. In comparison, TSUSF has a market cap of 2.7B. Regarding current trading prices, ZRSEF is priced at $10.57, while TSUSF trades at $55.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZRSEF currently has a P/E ratio of -2.14, whereas TSUSF's P/E ratio is 16.87. In terms of profitability, ZRSEF's ROE is -0.26%, compared to TSUSF's ROE of +0.06%. Regarding short-term risk, ZRSEF is more volatile compared to TSUSF. This indicates potentially higher risk in terms of short-term price fluctuations for ZRSEF.Check TSUSF's competition here
ZRSEF vs SAEYY Comparison August 2025
ZRSEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZRSEF stands at 508.5M. In comparison, SAEYY has a market cap of 2.4B. Regarding current trading prices, ZRSEF is priced at $10.57, while SAEYY trades at $11.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZRSEF currently has a P/E ratio of -2.14, whereas SAEYY's P/E ratio is -41.96. In terms of profitability, ZRSEF's ROE is -0.26%, compared to SAEYY's ROE of -0.10%. Regarding short-term risk, ZRSEF is more volatile compared to SAEYY. This indicates potentially higher risk in terms of short-term price fluctuations for ZRSEF.Check SAEYY's competition here
ZRSEF vs HTSUY Comparison August 2025
ZRSEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZRSEF stands at 508.5M. In comparison, HTSUY has a market cap of 2B. Regarding current trading prices, ZRSEF is priced at $10.57, while HTSUY trades at $6.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZRSEF currently has a P/E ratio of -2.14, whereas HTSUY's P/E ratio is N/A. In terms of profitability, ZRSEF's ROE is -0.26%, compared to HTSUY's ROE of +0.08%. Regarding short-term risk, ZRSEF is more volatile compared to HTSUY. This indicates potentially higher risk in terms of short-term price fluctuations for ZRSEF.Check HTSUY's competition here
ZRSEF vs BJTRF Comparison August 2025
ZRSEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZRSEF stands at 508.5M. In comparison, BJTRF has a market cap of 542.8M. Regarding current trading prices, ZRSEF is priced at $10.57, while BJTRF trades at $0.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZRSEF currently has a P/E ratio of -2.14, whereas BJTRF's P/E ratio is 8.10. In terms of profitability, ZRSEF's ROE is -0.26%, compared to BJTRF's ROE of +0.03%. Regarding short-term risk, ZRSEF is more volatile compared to BJTRF. This indicates potentially higher risk in terms of short-term price fluctuations for ZRSEF.Check BJTRF's competition here
ZRSEF vs NVACF Comparison August 2025
ZRSEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZRSEF stands at 508.5M. In comparison, NVACF has a market cap of 78.5M. Regarding current trading prices, ZRSEF is priced at $10.57, while NVACF trades at $1.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZRSEF currently has a P/E ratio of -2.14, whereas NVACF's P/E ratio is 31.60. In terms of profitability, ZRSEF's ROE is -0.26%, compared to NVACF's ROE of +0.02%. Regarding short-term risk, ZRSEF is more volatile compared to NVACF. This indicates potentially higher risk in terms of short-term price fluctuations for ZRSEF.Check NVACF's competition here
ZRSEF vs HTPRF Comparison August 2025
ZRSEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZRSEF stands at 508.5M. In comparison, HTPRF has a market cap of 12.1M. Regarding current trading prices, ZRSEF is priced at $10.57, while HTPRF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZRSEF currently has a P/E ratio of -2.14, whereas HTPRF's P/E ratio is -0.06. In terms of profitability, ZRSEF's ROE is -0.26%, compared to HTPRF's ROE of +0.11%. Regarding short-term risk, ZRSEF is more volatile compared to HTPRF. This indicates potentially higher risk in terms of short-term price fluctuations for ZRSEF.Check HTPRF's competition here
ZRSEF vs PNPL Comparison August 2025
ZRSEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZRSEF stands at 508.5M. In comparison, PNPL has a market cap of 10.2M. Regarding current trading prices, ZRSEF is priced at $10.57, while PNPL trades at $0.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZRSEF currently has a P/E ratio of -2.14, whereas PNPL's P/E ratio is -14.00. In terms of profitability, ZRSEF's ROE is -0.26%, compared to PNPL's ROE of +0.54%. Regarding short-term risk, ZRSEF is more volatile compared to PNPL. This indicates potentially higher risk in terms of short-term price fluctuations for ZRSEF.Check PNPL's competition here
ZRSEF vs ETBI Comparison August 2025
ZRSEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZRSEF stands at 508.5M. In comparison, ETBI has a market cap of 9M. Regarding current trading prices, ZRSEF is priced at $10.57, while ETBI trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZRSEF currently has a P/E ratio of -2.14, whereas ETBI's P/E ratio is -0.40. In terms of profitability, ZRSEF's ROE is -0.26%, compared to ETBI's ROE of +0.00%. Regarding short-term risk, ZRSEF is less volatile compared to ETBI. This indicates potentially lower risk in terms of short-term price fluctuations for ZRSEF.Check ETBI's competition here
ZRSEF vs HEWA Comparison August 2025
ZRSEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZRSEF stands at 508.5M. In comparison, HEWA has a market cap of 5.9M. Regarding current trading prices, ZRSEF is priced at $10.57, while HEWA trades at $0.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZRSEF currently has a P/E ratio of -2.14, whereas HEWA's P/E ratio is -4.59. In terms of profitability, ZRSEF's ROE is -0.26%, compared to HEWA's ROE of -0.02%. Regarding short-term risk, ZRSEF is more volatile compared to HEWA. This indicates potentially higher risk in terms of short-term price fluctuations for ZRSEF.Check HEWA's competition here
ZRSEF vs FFLWF Comparison August 2025
ZRSEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZRSEF stands at 508.5M. In comparison, FFLWF has a market cap of 5.4M. Regarding current trading prices, ZRSEF is priced at $10.57, while FFLWF trades at $0.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZRSEF currently has a P/E ratio of -2.14, whereas FFLWF's P/E ratio is -0.08. In terms of profitability, ZRSEF's ROE is -0.26%, compared to FFLWF's ROE of -0.97%. Regarding short-term risk, ZRSEF is more volatile compared to FFLWF. This indicates potentially higher risk in terms of short-term price fluctuations for ZRSEF.Check FFLWF's competition here
ZRSEF vs RLLVF Comparison August 2025
ZRSEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZRSEF stands at 508.5M. In comparison, RLLVF has a market cap of 5.3M. Regarding current trading prices, ZRSEF is priced at $10.57, while RLLVF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZRSEF currently has a P/E ratio of -2.14, whereas RLLVF's P/E ratio is -0.60. In terms of profitability, ZRSEF's ROE is -0.26%, compared to RLLVF's ROE of +2.21%. Regarding short-term risk, ZRSEF is less volatile compared to RLLVF. This indicates potentially lower risk in terms of short-term price fluctuations for ZRSEF.Check RLLVF's competition here
ZRSEF vs GABLF Comparison August 2025
ZRSEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZRSEF stands at 508.5M. In comparison, GABLF has a market cap of 2.7M. Regarding current trading prices, ZRSEF is priced at $10.57, while GABLF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZRSEF currently has a P/E ratio of -2.14, whereas GABLF's P/E ratio is -0.04. In terms of profitability, ZRSEF's ROE is -0.26%, compared to GABLF's ROE of +2.91%. Regarding short-term risk, ZRSEF is more volatile compared to GABLF. This indicates potentially higher risk in terms of short-term price fluctuations for ZRSEF.Check GABLF's competition here
ZRSEF vs SYDRF Comparison August 2025
ZRSEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZRSEF stands at 508.5M. In comparison, SYDRF has a market cap of 2.3M. Regarding current trading prices, ZRSEF is priced at $10.57, while SYDRF trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZRSEF currently has a P/E ratio of -2.14, whereas SYDRF's P/E ratio is 8.00. In terms of profitability, ZRSEF's ROE is -0.26%, compared to SYDRF's ROE of +0.96%. Regarding short-term risk, ZRSEF is more volatile compared to SYDRF. This indicates potentially higher risk in terms of short-term price fluctuations for ZRSEF.Check SYDRF's competition here
ZRSEF vs IWINF Comparison August 2025
ZRSEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZRSEF stands at 508.5M. In comparison, IWINF has a market cap of 1.7M. Regarding current trading prices, ZRSEF is priced at $10.57, while IWINF trades at $0.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZRSEF currently has a P/E ratio of -2.14, whereas IWINF's P/E ratio is -0.06. In terms of profitability, ZRSEF's ROE is -0.26%, compared to IWINF's ROE of -0.21%. Regarding short-term risk, ZRSEF is more volatile compared to IWINF. This indicates potentially higher risk in terms of short-term price fluctuations for ZRSEF.Check IWINF's competition here
ZRSEF vs LGNZZ Comparison August 2025
ZRSEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZRSEF stands at 508.5M. In comparison, LGNZZ has a market cap of 1.7M. Regarding current trading prices, ZRSEF is priced at $10.57, while LGNZZ trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZRSEF currently has a P/E ratio of -2.14, whereas LGNZZ's P/E ratio is N/A. In terms of profitability, ZRSEF's ROE is -0.26%, compared to LGNZZ's ROE of -0.16%. Regarding short-term risk, ZRSEF is more volatile compared to LGNZZ. This indicates potentially higher risk in terms of short-term price fluctuations for ZRSEF.Check LGNZZ's competition here
ZRSEF vs NUTTQ Comparison August 2025
ZRSEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZRSEF stands at 508.5M. In comparison, NUTTQ has a market cap of 1.1M. Regarding current trading prices, ZRSEF is priced at $10.57, while NUTTQ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZRSEF currently has a P/E ratio of -2.14, whereas NUTTQ's P/E ratio is N/A. In terms of profitability, ZRSEF's ROE is -0.26%, compared to NUTTQ's ROE of +3.01%. Regarding short-term risk, ZRSEF is less volatile compared to NUTTQ. This indicates potentially lower risk in terms of short-term price fluctuations for ZRSEF.Check NUTTQ's competition here
ZRSEF vs LGNYZ Comparison August 2025
ZRSEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZRSEF stands at 508.5M. In comparison, LGNYZ has a market cap of 791.1K. Regarding current trading prices, ZRSEF is priced at $10.57, while LGNYZ trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZRSEF currently has a P/E ratio of -2.14, whereas LGNYZ's P/E ratio is N/A. In terms of profitability, ZRSEF's ROE is -0.26%, compared to LGNYZ's ROE of -0.16%. Regarding short-term risk, ZRSEF is more volatile compared to LGNYZ. This indicates potentially higher risk in terms of short-term price fluctuations for ZRSEF.Check LGNYZ's competition here
ZRSEF vs CNBI Comparison August 2025
ZRSEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZRSEF stands at 508.5M. In comparison, CNBI has a market cap of 686.8K. Regarding current trading prices, ZRSEF is priced at $10.57, while CNBI trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZRSEF currently has a P/E ratio of -2.14, whereas CNBI's P/E ratio is N/A. In terms of profitability, ZRSEF's ROE is -0.26%, compared to CNBI's ROE of +0.17%. Regarding short-term risk, ZRSEF is more volatile compared to CNBI. This indicates potentially higher risk in terms of short-term price fluctuations for ZRSEF.Check CNBI's competition here
ZRSEF vs RADCQ Comparison August 2025
ZRSEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZRSEF stands at 508.5M. In comparison, RADCQ has a market cap of 559.7K. Regarding current trading prices, ZRSEF is priced at $10.57, while RADCQ trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZRSEF currently has a P/E ratio of -2.14, whereas RADCQ's P/E ratio is -0.00. In terms of profitability, ZRSEF's ROE is -0.26%, compared to RADCQ's ROE of +3.01%. Regarding short-term risk, ZRSEF is less volatile compared to RADCQ. This indicates potentially lower risk in terms of short-term price fluctuations for ZRSEF.Check RADCQ's competition here
ZRSEF vs AEGY Comparison August 2025
ZRSEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZRSEF stands at 508.5M. In comparison, AEGY has a market cap of 411.2K. Regarding current trading prices, ZRSEF is priced at $10.57, while AEGY trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZRSEF currently has a P/E ratio of -2.14, whereas AEGY's P/E ratio is N/A. In terms of profitability, ZRSEF's ROE is -0.26%, compared to AEGY's ROE of +0.00%. Regarding short-term risk, ZRSEF is more volatile compared to AEGY. This indicates potentially higher risk in terms of short-term price fluctuations for ZRSEF.Check AEGY's competition here
ZRSEF vs IPAH Comparison August 2025
ZRSEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZRSEF stands at 508.5M. In comparison, IPAH has a market cap of 273.6K. Regarding current trading prices, ZRSEF is priced at $10.57, while IPAH trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZRSEF currently has a P/E ratio of -2.14, whereas IPAH's P/E ratio is -0.05. In terms of profitability, ZRSEF's ROE is -0.26%, compared to IPAH's ROE of -0.82%. Regarding short-term risk, ZRSEF is less volatile compared to IPAH. This indicates potentially lower risk in terms of short-term price fluctuations for ZRSEF.Check IPAH's competition here
ZRSEF vs SCRCQ Comparison August 2025
ZRSEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZRSEF stands at 508.5M. In comparison, SCRCQ has a market cap of 141.1K. Regarding current trading prices, ZRSEF is priced at $10.57, while SCRCQ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZRSEF currently has a P/E ratio of -2.14, whereas SCRCQ's P/E ratio is -0.01. In terms of profitability, ZRSEF's ROE is -0.26%, compared to SCRCQ's ROE of +1.63%. Regarding short-term risk, ZRSEF is less volatile compared to SCRCQ. This indicates potentially lower risk in terms of short-term price fluctuations for ZRSEF.Check SCRCQ's competition here
ZRSEF vs KIARF Comparison August 2025
ZRSEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZRSEF stands at 508.5M. In comparison, KIARF has a market cap of 132K. Regarding current trading prices, ZRSEF is priced at $10.57, while KIARF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZRSEF currently has a P/E ratio of -2.14, whereas KIARF's P/E ratio is N/A. In terms of profitability, ZRSEF's ROE is -0.26%, compared to KIARF's ROE of -1.47%. Regarding short-term risk, ZRSEF is less volatile compared to KIARF. This indicates potentially lower risk in terms of short-term price fluctuations for ZRSEF.Check KIARF's competition here
ZRSEF vs FOGCF Comparison August 2025
ZRSEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZRSEF stands at 508.5M. In comparison, FOGCF has a market cap of 97.2K. Regarding current trading prices, ZRSEF is priced at $10.57, while FOGCF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZRSEF currently has a P/E ratio of -2.14, whereas FOGCF's P/E ratio is N/A. In terms of profitability, ZRSEF's ROE is -0.26%, compared to FOGCF's ROE of +3.99%. Regarding short-term risk, ZRSEF is less volatile compared to FOGCF. This indicates potentially lower risk in terms of short-term price fluctuations for ZRSEF.Check FOGCF's competition here
ZRSEF vs MDIN Comparison August 2025
ZRSEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZRSEF stands at 508.5M. In comparison, MDIN has a market cap of 90.3K. Regarding current trading prices, ZRSEF is priced at $10.57, while MDIN trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZRSEF currently has a P/E ratio of -2.14, whereas MDIN's P/E ratio is N/A. In terms of profitability, ZRSEF's ROE is -0.26%, compared to MDIN's ROE of +0.36%. Regarding short-term risk, ZRSEF is less volatile compared to MDIN. This indicates potentially lower risk in terms of short-term price fluctuations for ZRSEF.Check MDIN's competition here
ZRSEF vs OXIHF Comparison August 2025
ZRSEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZRSEF stands at 508.5M. In comparison, OXIHF has a market cap of 65.7K. Regarding current trading prices, ZRSEF is priced at $10.57, while OXIHF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZRSEF currently has a P/E ratio of -2.14, whereas OXIHF's P/E ratio is N/A. In terms of profitability, ZRSEF's ROE is -0.26%, compared to OXIHF's ROE of +3.30%. Regarding short-term risk, ZRSEF is less volatile compared to OXIHF. This indicates potentially lower risk in terms of short-term price fluctuations for ZRSEF.Check OXIHF's competition here
ZRSEF vs LGNDZ Comparison August 2025
ZRSEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZRSEF stands at 508.5M. In comparison, LGNDZ has a market cap of 62.5K. Regarding current trading prices, ZRSEF is priced at $10.57, while LGNDZ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZRSEF currently has a P/E ratio of -2.14, whereas LGNDZ's P/E ratio is N/A. In terms of profitability, ZRSEF's ROE is -0.26%, compared to LGNDZ's ROE of -0.16%. Regarding short-term risk, ZRSEF is more volatile compared to LGNDZ. This indicates potentially higher risk in terms of short-term price fluctuations for ZRSEF.Check LGNDZ's competition here
ZRSEF vs IMMB Comparison August 2025
ZRSEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZRSEF stands at 508.5M. In comparison, IMMB has a market cap of 57.5K. Regarding current trading prices, ZRSEF is priced at $10.57, while IMMB trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZRSEF currently has a P/E ratio of -2.14, whereas IMMB's P/E ratio is N/A. In terms of profitability, ZRSEF's ROE is -0.26%, compared to IMMB's ROE of -0.09%. Regarding short-term risk, ZRSEF is more volatile compared to IMMB. This indicates potentially higher risk in terms of short-term price fluctuations for ZRSEF.Check IMMB's competition here
ZRSEF vs LGNXZ Comparison August 2025
ZRSEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZRSEF stands at 508.5M. In comparison, LGNXZ has a market cap of 45.1K. Regarding current trading prices, ZRSEF is priced at $10.57, while LGNXZ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZRSEF currently has a P/E ratio of -2.14, whereas LGNXZ's P/E ratio is N/A. In terms of profitability, ZRSEF's ROE is -0.26%, compared to LGNXZ's ROE of -0.16%. Regarding short-term risk, ZRSEF is more volatile compared to LGNXZ. This indicates potentially higher risk in terms of short-term price fluctuations for ZRSEF.Check LGNXZ's competition here
ZRSEF vs AXMP Comparison August 2025
ZRSEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZRSEF stands at 508.5M. In comparison, AXMP has a market cap of 40.9K. Regarding current trading prices, ZRSEF is priced at $10.57, while AXMP trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZRSEF currently has a P/E ratio of -2.14, whereas AXMP's P/E ratio is 0.05. In terms of profitability, ZRSEF's ROE is -0.26%, compared to AXMP's ROE of N/A. Regarding short-term risk, ZRSEF is more volatile compared to AXMP. This indicates potentially higher risk in terms of short-term price fluctuations for ZRSEF.Check AXMP's competition here
ZRSEF vs DECN Comparison August 2025
ZRSEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZRSEF stands at 508.5M. In comparison, DECN has a market cap of 35.5K. Regarding current trading prices, ZRSEF is priced at $10.57, while DECN trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZRSEF currently has a P/E ratio of -2.14, whereas DECN's P/E ratio is N/A. In terms of profitability, ZRSEF's ROE is -0.26%, compared to DECN's ROE of +0.00%. Regarding short-term risk, ZRSEF is more volatile compared to DECN. This indicates potentially higher risk in terms of short-term price fluctuations for ZRSEF.Check DECN's competition here
ZRSEF vs HADV Comparison August 2025
ZRSEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZRSEF stands at 508.5M. In comparison, HADV has a market cap of 32.2K. Regarding current trading prices, ZRSEF is priced at $10.57, while HADV trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZRSEF currently has a P/E ratio of -2.14, whereas HADV's P/E ratio is N/A. In terms of profitability, ZRSEF's ROE is -0.26%, compared to HADV's ROE of +0.83%. Regarding short-term risk, ZRSEF is more volatile compared to HADV. This indicates potentially higher risk in terms of short-term price fluctuations for ZRSEF.Check HADV's competition here
ZRSEF vs SPPH Comparison August 2025
ZRSEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZRSEF stands at 508.5M. In comparison, SPPH has a market cap of 29.4K. Regarding current trading prices, ZRSEF is priced at $10.57, while SPPH trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZRSEF currently has a P/E ratio of -2.14, whereas SPPH's P/E ratio is -0.03. In terms of profitability, ZRSEF's ROE is -0.26%, compared to SPPH's ROE of -0.50%. Regarding short-term risk, ZRSEF is less volatile compared to SPPH. This indicates potentially lower risk in terms of short-term price fluctuations for ZRSEF.Check SPPH's competition here
ZRSEF vs WPHM Comparison August 2025
ZRSEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZRSEF stands at 508.5M. In comparison, WPHM has a market cap of 23.2K. Regarding current trading prices, ZRSEF is priced at $10.57, while WPHM trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZRSEF currently has a P/E ratio of -2.14, whereas WPHM's P/E ratio is -0.01. In terms of profitability, ZRSEF's ROE is -0.26%, compared to WPHM's ROE of -1.56%. Regarding short-term risk, ZRSEF is less volatile compared to WPHM. This indicates potentially lower risk in terms of short-term price fluctuations for ZRSEF.Check WPHM's competition here
ZRSEF vs CAFS Comparison August 2025
ZRSEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZRSEF stands at 508.5M. In comparison, CAFS has a market cap of 19.9K. Regarding current trading prices, ZRSEF is priced at $10.57, while CAFS trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZRSEF currently has a P/E ratio of -2.14, whereas CAFS's P/E ratio is N/A. In terms of profitability, ZRSEF's ROE is -0.26%, compared to CAFS's ROE of +1.94%. Regarding short-term risk, ZRSEF is more volatile compared to CAFS. This indicates potentially higher risk in terms of short-term price fluctuations for ZRSEF.Check CAFS's competition here
ZRSEF vs TSTS Comparison August 2025
ZRSEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZRSEF stands at 508.5M. In comparison, TSTS has a market cap of 12.8K. Regarding current trading prices, ZRSEF is priced at $10.57, while TSTS trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZRSEF currently has a P/E ratio of -2.14, whereas TSTS's P/E ratio is N/A. In terms of profitability, ZRSEF's ROE is -0.26%, compared to TSTS's ROE of +2.32%. Regarding short-term risk, ZRSEF is less volatile compared to TSTS. This indicates potentially lower risk in terms of short-term price fluctuations for ZRSEF.Check TSTS's competition here
ZRSEF vs IXSBF Comparison August 2025
ZRSEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZRSEF stands at 508.5M. In comparison, IXSBF has a market cap of 12.6K. Regarding current trading prices, ZRSEF is priced at $10.57, while IXSBF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZRSEF currently has a P/E ratio of -2.14, whereas IXSBF's P/E ratio is -0.01. In terms of profitability, ZRSEF's ROE is -0.26%, compared to IXSBF's ROE of +1.90%. Regarding short-term risk, ZRSEF is less volatile compared to IXSBF. This indicates potentially lower risk in terms of short-term price fluctuations for ZRSEF.Check IXSBF's competition here
ZRSEF vs ALST Comparison August 2025
ZRSEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZRSEF stands at 508.5M. In comparison, ALST has a market cap of 11K. Regarding current trading prices, ZRSEF is priced at $10.57, while ALST trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZRSEF currently has a P/E ratio of -2.14, whereas ALST's P/E ratio is N/A. In terms of profitability, ZRSEF's ROE is -0.26%, compared to ALST's ROE of +0.13%. Regarding short-term risk, ZRSEF is more volatile compared to ALST. This indicates potentially higher risk in terms of short-term price fluctuations for ZRSEF.Check ALST's competition here
ZRSEF vs VIAP Comparison August 2025
ZRSEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZRSEF stands at 508.5M. In comparison, VIAP has a market cap of 10.3K. Regarding current trading prices, ZRSEF is priced at $10.57, while VIAP trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZRSEF currently has a P/E ratio of -2.14, whereas VIAP's P/E ratio is -0.05. In terms of profitability, ZRSEF's ROE is -0.26%, compared to VIAP's ROE of +0.65%. Regarding short-term risk, ZRSEF is less volatile compared to VIAP. This indicates potentially lower risk in terms of short-term price fluctuations for ZRSEF.Check VIAP's competition here
ZRSEF vs HBOSF Comparison August 2025
ZRSEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZRSEF stands at 508.5M. In comparison, HBOSF has a market cap of 7.8K. Regarding current trading prices, ZRSEF is priced at $10.57, while HBOSF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZRSEF currently has a P/E ratio of -2.14, whereas HBOSF's P/E ratio is 0.03. In terms of profitability, ZRSEF's ROE is -0.26%, compared to HBOSF's ROE of +6.69%. Regarding short-term risk, ZRSEF is more volatile compared to HBOSF. This indicates potentially higher risk in terms of short-term price fluctuations for ZRSEF.Check HBOSF's competition here
ZRSEF vs PXYN Comparison August 2025
ZRSEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZRSEF stands at 508.5M. In comparison, PXYN has a market cap of 6.3K. Regarding current trading prices, ZRSEF is priced at $10.57, while PXYN trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZRSEF currently has a P/E ratio of -2.14, whereas PXYN's P/E ratio is N/A. In terms of profitability, ZRSEF's ROE is -0.26%, compared to PXYN's ROE of -0.20%. Regarding short-term risk, ZRSEF is less volatile compared to PXYN. This indicates potentially lower risk in terms of short-term price fluctuations for ZRSEF.Check PXYN's competition here
ZRSEF vs IYXI Comparison August 2025
ZRSEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZRSEF stands at 508.5M. In comparison, IYXI has a market cap of 5.3K. Regarding current trading prices, ZRSEF is priced at $10.57, while IYXI trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZRSEF currently has a P/E ratio of -2.14, whereas IYXI's P/E ratio is N/A. In terms of profitability, ZRSEF's ROE is -0.26%, compared to IYXI's ROE of +1.71%. Regarding short-term risk, ZRSEF is more volatile compared to IYXI. This indicates potentially higher risk in terms of short-term price fluctuations for ZRSEF.Check IYXI's competition here
ZRSEF vs NEWG Comparison August 2025
ZRSEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZRSEF stands at 508.5M. In comparison, NEWG has a market cap of 2.3K. Regarding current trading prices, ZRSEF is priced at $10.57, while NEWG trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZRSEF currently has a P/E ratio of -2.14, whereas NEWG's P/E ratio is N/A. In terms of profitability, ZRSEF's ROE is -0.26%, compared to NEWG's ROE of +0.40%. Regarding short-term risk, ZRSEF is less volatile compared to NEWG. This indicates potentially lower risk in terms of short-term price fluctuations for ZRSEF.Check NEWG's competition here
ZRSEF vs FSPM Comparison August 2025
ZRSEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZRSEF stands at 508.5M. In comparison, FSPM has a market cap of 1.3K. Regarding current trading prices, ZRSEF is priced at $10.57, while FSPM trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZRSEF currently has a P/E ratio of -2.14, whereas FSPM's P/E ratio is N/A. In terms of profitability, ZRSEF's ROE is -0.26%, compared to FSPM's ROE of N/A. Regarding short-term risk, ZRSEF is more volatile compared to FSPM. This indicates potentially higher risk in terms of short-term price fluctuations for ZRSEF.Check FSPM's competition here
ZRSEF vs GRPI Comparison August 2025
ZRSEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZRSEF stands at 508.5M. In comparison, GRPI has a market cap of 1K. Regarding current trading prices, ZRSEF is priced at $10.57, while GRPI trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZRSEF currently has a P/E ratio of -2.14, whereas GRPI's P/E ratio is -0.02. In terms of profitability, ZRSEF's ROE is -0.26%, compared to GRPI's ROE of +0.09%. Regarding short-term risk, ZRSEF is more volatile compared to GRPI. This indicates potentially higher risk in terms of short-term price fluctuations for ZRSEF.Check GRPI's competition here
ZRSEF vs OMHE Comparison August 2025
ZRSEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZRSEF stands at 508.5M. In comparison, OMHE has a market cap of 983. Regarding current trading prices, ZRSEF is priced at $10.57, while OMHE trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZRSEF currently has a P/E ratio of -2.14, whereas OMHE's P/E ratio is N/A. In terms of profitability, ZRSEF's ROE is -0.26%, compared to OMHE's ROE of +0.73%. Regarding short-term risk, ZRSEF is more volatile compared to OMHE. This indicates potentially higher risk in terms of short-term price fluctuations for ZRSEF.Check OMHE's competition here
ZRSEF vs RBII Comparison August 2025
ZRSEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZRSEF stands at 508.5M. In comparison, RBII has a market cap of 499. Regarding current trading prices, ZRSEF is priced at $10.57, while RBII trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZRSEF currently has a P/E ratio of -2.14, whereas RBII's P/E ratio is N/A. In terms of profitability, ZRSEF's ROE is -0.26%, compared to RBII's ROE of -0.04%. Regarding short-term risk, ZRSEF is more volatile compared to RBII. This indicates potentially higher risk in terms of short-term price fluctuations for ZRSEF.Check RBII's competition here
ZRSEF vs ACGJ Comparison August 2025
ZRSEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZRSEF stands at 508.5M. In comparison, ACGJ has a market cap of 324. Regarding current trading prices, ZRSEF is priced at $10.57, while ACGJ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZRSEF currently has a P/E ratio of -2.14, whereas ACGJ's P/E ratio is -0.00. In terms of profitability, ZRSEF's ROE is -0.26%, compared to ACGJ's ROE of N/A. Regarding short-term risk, ZRSEF is more volatile compared to ACGJ. This indicates potentially higher risk in terms of short-term price fluctuations for ZRSEF.Check ACGJ's competition here
ZRSEF vs MDVLQ Comparison August 2025
ZRSEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZRSEF stands at 508.5M. In comparison, MDVLQ has a market cap of 161. Regarding current trading prices, ZRSEF is priced at $10.57, while MDVLQ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZRSEF currently has a P/E ratio of -2.14, whereas MDVLQ's P/E ratio is N/A. In terms of profitability, ZRSEF's ROE is -0.26%, compared to MDVLQ's ROE of -2.39%. Regarding short-term risk, ZRSEF is more volatile compared to MDVLQ. This indicates potentially higher risk in terms of short-term price fluctuations for ZRSEF.Check MDVLQ's competition here
ZRSEF vs ISHI Comparison August 2025
ZRSEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZRSEF stands at 508.5M. In comparison, ISHI has a market cap of 5. Regarding current trading prices, ZRSEF is priced at $10.57, while ISHI trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZRSEF currently has a P/E ratio of -2.14, whereas ISHI's P/E ratio is N/A. In terms of profitability, ZRSEF's ROE is -0.26%, compared to ISHI's ROE of N/A. Regarding short-term risk, ZRSEF is more volatile compared to ISHI. This indicates potentially higher risk in terms of short-term price fluctuations for ZRSEF.Check ISHI's competition here
ZRSEF vs SYNI Comparison August 2025
ZRSEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZRSEF stands at 508.5M. In comparison, SYNI has a market cap of 3. Regarding current trading prices, ZRSEF is priced at $10.57, while SYNI trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZRSEF currently has a P/E ratio of -2.14, whereas SYNI's P/E ratio is -0.00. In terms of profitability, ZRSEF's ROE is -0.26%, compared to SYNI's ROE of N/A. Regarding short-term risk, ZRSEF is more volatile compared to SYNI. This indicates potentially higher risk in terms of short-term price fluctuations for ZRSEF.Check SYNI's competition here
ZRSEF vs TFSHF Comparison August 2025
ZRSEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZRSEF stands at 508.5M. In comparison, TFSHF has a market cap of 0. Regarding current trading prices, ZRSEF is priced at $10.57, while TFSHF trades at $1.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZRSEF currently has a P/E ratio of -2.14, whereas TFSHF's P/E ratio is N/A. In terms of profitability, ZRSEF's ROE is -0.26%, compared to TFSHF's ROE of N/A. Regarding short-term risk, ZRSEF is more volatile compared to TFSHF. This indicates potentially higher risk in terms of short-term price fluctuations for ZRSEF.Check TFSHF's competition here
ZRSEF vs MDSI Comparison August 2025
ZRSEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZRSEF stands at 508.5M. In comparison, MDSI has a market cap of 0. Regarding current trading prices, ZRSEF is priced at $10.57, while MDSI trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZRSEF currently has a P/E ratio of -2.14, whereas MDSI's P/E ratio is N/A. In terms of profitability, ZRSEF's ROE is -0.26%, compared to MDSI's ROE of N/A. Regarding short-term risk, ZRSEF is more volatile compared to MDSI. This indicates potentially higher risk in terms of short-term price fluctuations for ZRSEF.Check MDSI's competition here
ZRSEF vs GHTI Comparison August 2025
ZRSEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZRSEF stands at 508.5M. In comparison, GHTI has a market cap of 0. Regarding current trading prices, ZRSEF is priced at $10.57, while GHTI trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZRSEF currently has a P/E ratio of -2.14, whereas GHTI's P/E ratio is N/A. In terms of profitability, ZRSEF's ROE is -0.26%, compared to GHTI's ROE of N/A. Regarding short-term risk, ZRSEF is less volatile compared to GHTI. This indicates potentially lower risk in terms of short-term price fluctuations for ZRSEF.Check GHTI's competition here